FDA Advisory Committees: 2025 drug approvals granted by advisors receiving undisclosed consulting fees from manufacturers
February 14, 2026 • Ekalavya Hansaj
The 'Expert Panel' Loophole: Investigating the 2025 Shift from FACA-Regulated AdComms The following section investigates the systemic evasion of Federal Advisory Committee Act (FACA) regulations…